Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2s,2s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine Citrate Monohydrate
2. (2s,3s)-2-benzhydryl-n-(5-(tert-butyl)-2-methoxybenzyl)quinuclidin-3-amine 2-hydroxypropane-1,2,3-tricarboxylate Hydrate
3. (2s,3s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine Citrate Monohydrate
4. 2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine Citrate Monohydrate
5. Maropitant
1. 359875-09-5
2. Cerenia
3. Maropitant Citrate Hydrate
4. Maropitant Citrate [usan]
5. Cj-11,972
6. Maropitant Citrate Monohydrate
7. Lxn6s3999x
8. Cj-11972
9. Maropitant Citrate (usan)
10. (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine Citrate Hydrate
11. (2s,3s)-n-(5-(1,1-dimethylethyl)-2-methoxybenzyl)-2-(diphenylmethyl)-1-azabicyclo(2.2.2)octan-3-amine 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Monohydrate
12. 1-azabicyclo(2.2.2)octan-3-amine, N-((5-(1,1-dimethylethyl)-2-methoxyphenyl)methyl)-2-(diphenylmethyl)-, (2s,3s)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Monohydrate
13. Unii-lxn6s3999x
14. Starbld0016570
15. Schembl4184310
16. Chembl2107353
17. Dtxsid70957411
18. Ex-a3585
19. Bs-49286
20. Maropitant Citrate Monohydrate [mi]
21. D04860
22. E83993
23. Maropitant Citrate [ema Epar Veterinary]
24. (2-benzhydryl-1-aza-bicyclo(2.2.2)oct-3-yl)-(5-tert-butyl-2-methoxybenzyl)amine
25. (2s,3s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl) Quinuclidin-3-amine Citrate Monohydrate
26. (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine;2-hydroxypropane-1,2,3-tricarboxylic Acid;hydrate
27. 2-hydroxypropane-1,2,3-tricarboxylic Acid--n-[(5-tert-butyl-2-methoxyphenyl)methyl]-2-(diphenylmethyl)-1-azabicyclo[2.2.2]octan-3-amine--water (1/1/1)
Molecular Weight | 678.8 g/mol |
---|---|
Molecular Formula | C38H50N2O9 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 13 |
Exact Mass | 678.35163118 g/mol |
Monoisotopic Mass | 678.35163118 g/mol |
Topological Polar Surface Area | 158 Ų |
Heavy Atom Count | 49 |
Formal Charge | 0 |
Complexity | 848 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
* Tablets:
Dogs:
- For the prevention of nausea induced by chemotherapy.
- For the prevention of vomiting induced by motion sickness.
- For the prevention and treatment of vomiting, in conjunction with Cerenia solution for injection and in combination with other supportive measures.
* Solution for injection:
Dogs:
- For the treatment and prevention of nausea induced by chemotherapy.
- For the prevention of vomiting except that induced by motion sickness.
- For the treatment of vomiting, in combination with other supportive measures.
- For the prevention of perioperative nausea and vomiting and improvement in recovery from general anaesthesia after use of the -opiate receptor agonist morphine.
Cats:
- For the prevention of vomiting and the reduction of nausea, except that induced by motion sickness.
- For the treatment of vomiting, in combination with other supportive measures.
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
QA04AD90
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?